Experiments showed metformin and its photoproducts caused growth inhibition and malformations in aquatic species, indicating greater ecological risks.
Photochemical degradation of the antidiabetic drug metformin in the presence of a quinone sensitiser was investigated under environmentally relevant UV light. Degradation products were identified using UHPLC-Q-TOF. The effects of the resulting photoproduct mixture and metformin itself (50-100 µg l⁻¹) were assessed on four aquatic species representing different trophic levels: Desmodesmus subspicatus, Lemna minor, Daphnia magna and Danio rerio embryos. The photoproduct mixture caused growth inhibition in photosynthesising organisms, reproductive disruption in Daphnia, developmental malformations in fish embryos, and significant changes in oxidative stress markers. This study provides the first evidence that photochemically generated transformation products of metformin are significantly more toxic than the parent compound, even at environmentally relevant concentrations. These findings highlight the importance of including not only parent pharmaceuticals but also their photoproducts in environmental risk assessments, as the latter may pose a greater ecological hazard in surface waters.
No takes yet. Share an insight, caveat, or question.
Poncarová et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: